Eurobio Scientific (XPAR:ALERS) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:ALERS Eurobio Scientific XPAR:ALERS
68 GF Score
Price €20.70
GF Value €25.28
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Eurobio Scientific Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.


XPAR:ALERS vs ABT, SYK, MDT: Short Interest Comparison

For the Medical Devices subindustry, Eurobio Scientific's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eurobio Scientific Short Interest vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Eurobio Scientific's Short Interest distribution charts can be found below:

* The bar in red indicates where Eurobio Scientific's Short Interest falls into.


XPAR:ALERS
68GF Score
Eurobio Scientific XPAR:ALERS
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Eurobio Scientific (XPAR:ALERS) Overvalued in 2026?

Based on GuruFocus' analysis, Eurobio Scientific stock appears to be undervalued. The current stock price of €20.70 is trading 18.1% below its estimated GF Value™ of €25.28. GuruFocus considers Eurobio Scientific to be Modestly Undervalued.

Key valuation signals for XPAR:ALERS:

  • Short Interest:
  • GF Value™: €25.28 vs. price of €20.70 (18.1% below fair value)
  • GF Score™: 68/100 with 5 warning signs

No single metric tells the full story. See the XPAR:ALERS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Eurobio Scientific Business Description

Other Exchanges E8TN:Germany
Address 63-65 Boulevard Massena, Paris, FRA, 75013
Eurobio Scientific is one of the leading providers of specialty in vitro diagnostics and life-science solutions. The product portfolio includes Tetanos Quick Stick, BJI InoPlex, AlloMap, and TEDAC Consortium.
68GF Score

Get the complete analysis for XPAR:ALERS

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€20.70
Price
€25.28
GF Value